{
    "organizations": [],
    "uuid": "7aba0e458fc5bcdbb0a0e990f5d2fb000910322d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-chart-industries-reports-q1-earnin/brief-chart-industries-reports-q1-earnings-per-share-0-18-idUSASC09WFC",
    "ord_in_thread": 0,
    "title": "BRIEF-Chart Industries Reports Q1 Earnings Per Share $0.18",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19, 2018 / 10:08 AM / Updated 15 minutes ago BRIEF-Chart Industries Reports Q1 Earnings Per Share $0.18 Reuters Staff \nApril 19 (Reuters) - Chart Industries Inc: * Q1 EARNINGS PER SHARE $0.18 \n* Q1 EARNINGS PER SHARE VIEW $0.19 — THOMSON REUTERS I/B/E/S \n* SEES FY 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.75 TO $2.00 * SEES FY 2018 SALES $1.15 BILLION TO $1.2 BILLION \n* Q1 SALES $279.7 MILLION VERSUS I/B/E/S VIEW $263.4 MILLION \n* EXPECT CAPITAL EXPENDITURES FOR 2018 WILL BE IN RANGE OF $35 MILLION TO $45 MILLION \n* EXPECT CAPITAL EXPENDITURES FOR 2018 WILL BE IN RANGE OF $35 MILLION TO $45 MILLION \n* FY2018 EARNINGS PER SHARE VIEW $1.82, REVENUE VIEW $1.18 BILLION — THOMSON REUTERS I/B/E/S \n* CHART INDUSTRIES - FY 2018 GUIDANCE INCLUDES IMPACT FROM REVENUE RECOGNITION ACCOUNTING STANDARD CHANGE WHICH WAS ADOPTED EFFECTIVE JAN 1, 2018 \n* CHART INDUSTRIES - IMPACT FROM REVENUE RECOGNITION ACCOUNTING STANDARD CHANGE ADOPTEED IN JAN 1, 2018 EXPECTED TO BE IMMATERIAL ON A FULL YEAR BASIS \n* CHART INDUSTRIES - STRATEGIC REVIEW OF OXYGEN-RELATED PRODUCT LINES WITHIN BIOMEDICAL SEGMENT IS UNDERWAY Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-04-19T13:07:00.000+03:00",
    "crawled": "2018-04-19T13:32:08.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "updated",
        "minute",
        "ago",
        "industry",
        "report",
        "q1",
        "earnings",
        "per",
        "share",
        "reuters",
        "staff",
        "april",
        "reuters",
        "chart",
        "industry",
        "inc",
        "q1",
        "earnings",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "see",
        "fy",
        "adjusted",
        "earnings",
        "per",
        "share",
        "see",
        "fy",
        "sale",
        "billion",
        "billion",
        "q1",
        "sale",
        "million",
        "versus",
        "view",
        "million",
        "expect",
        "capital",
        "expenditure",
        "range",
        "million",
        "million",
        "expect",
        "capital",
        "expenditure",
        "range",
        "million",
        "million",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "chart",
        "industry",
        "fy",
        "guidance",
        "includes",
        "impact",
        "revenue",
        "recognition",
        "accounting",
        "standard",
        "change",
        "adopted",
        "effective",
        "jan",
        "chart",
        "industry",
        "impact",
        "revenue",
        "recognition",
        "accounting",
        "standard",
        "change",
        "adopteed",
        "jan",
        "expected",
        "immaterial",
        "full",
        "year",
        "basis",
        "chart",
        "industry",
        "strategic",
        "review",
        "product",
        "line",
        "within",
        "biomedical",
        "segment",
        "underway",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}